Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > PA Providers

Dr. Muhammad Rizvi, MD

Accepting New Patients

(Muhammad A. Rizvi, MD)

(821 Ratings)

Specializes in: Medical Oncology, Hematology (Blood Disorders) and General Practice

Dow University of Health Sciences (2001)

Professional interests include: blood disorders, cancer, intrathecal chemotherapy (into the spinal fluid), and more.

1240 SOUTH CEDAR CREST BOULEVARD SUITE 401
Allentown, PA 18103

(610) 402-7880

Dr. Muhammad Rizvi, MD is a medical oncologist in Allentown, PA specializing in medical oncology, hematology (blood disorders) and general practice. He graduated from Dow University of Health Sciences in 2001 and has 23 years of experience. Dr. Muhammad Rizvi, MD is affiliated with Lehigh Valley Physician Group (LVPG), Lehigh Valley Health Network and LVH Hematology Oncology-1240 Cedar Crest.

Office Locations

Address:

1240 SOUTH CEDAR CREST BOULEVARD SUITE 401
Allentown, PA 18103

hospital care	71
inpatient care	71

**Gender**
Male	19
Female	39

**Ethnicity**
Non-Hispanic White	47
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	18
From 75 to 84	13
85 and over	14
Less than 65	13

Hypertension	75
High Cholesterol	59
Stroke	0
Ischemic Heart Disease	64
Depression	52
Chronic Kidney Disease	48
Asthma	21
Osteoperosis	28
Atrial Fibrilation	24
Heart Failure	43
Chronic Obstructive Pulmonary Disease	36
Diabetes	38
Dementia	0
Cancer	0

blood draw	16
doctor visit	8
hospital care	71
inpatient care	71
lab tests	26

**Gender**
Male	37
Female	58

**Age**
From 65 to 74	38
From 75 to 84	35
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	65
Stroke	0
Ischemic Heart Disease	48
Depression	24
Chronic Kidney Disease	48
Asthma	13
Osteoperosis	16
Atrial Fibrilation	19
Heart Failure	37
Chronic Obstructive Pulmonary Disease	36
Diabetes	38
Dementia	0
Cancer	48

biological response modifier (BRM) therapy	178
blood draw	346
chemotherapy	178
doctor visit	1111
hospital care	567
inpatient care	567
lab tests	1000
minimally invasive procedures	230
port flush	31
preventive care	10
vaccines	11

**Gender**
Male	532
Female	732

**Ethnicity**
Non-Hispanic White	1148
Black	74
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	522
From 75 to 84	434
85 and over	168
Less than 65	140

Hypertension	75
High Cholesterol	65
Stroke	9
Ischemic Heart Disease	50
Depression	25
Chronic Kidney Disease	41
Asthma	19
Osteoperosis	9
Atrial Fibrilation	20
Heart Failure	43
Chronic Obstructive Pulmonary Disease	32
Diabetes	39
Dementia	11
Cancer	40

biological response modifier (BRM) therapy	93
blood draw	217
chemotherapy	93
doctor visit	934
hospital care	339
inpatient care	339
lab tests	650
minimally invasive procedures	163
preventive care	10

**Gender**
Male	286
Female	338

**Ethnicity**
Non-Hispanic White	566
Black	31
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	257
From 75 to 84	203
85 and over	74
Less than 65	90

Hypertension	75
High Cholesterol	62
Stroke	8
Ischemic Heart Disease	44
Depression	24
Chronic Kidney Disease	46
Asthma	30
Osteoperosis	9
Atrial Fibrilation	15
Heart Failure	34
Chronic Obstructive Pulmonary Disease	29
Diabetes	38
Dementia	10
Cancer	38

blood draw	25
doctor visit	600
hospital care	279
inpatient care	279
lab tests	25

**Gender**
Male	194
Female	221

**Ethnicity**
Non-Hispanic White	372
Black	14
Hispanic	18
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	186
From 75 to 84	134
85 and over	43
Less than 65	52

Hypertension	75
High Cholesterol	63
Stroke	9
Ischemic Heart Disease	45
Depression	32
Chronic Kidney Disease	50
Asthma	10
Osteoperosis	12
Atrial Fibrilation	19
Heart Failure	31
Chronic Obstructive Pulmonary Disease	23
Diabetes	34
Dementia	11
Cancer	41

blood draw	32
doctor visit	801
hospital care	168
inpatient care	168
lab tests	30

**Gender**
Male	165
Female	239

**Ethnicity**
Non-Hispanic White	361
Black	0
Hispanic	17
Asian	0
Other	12
Native American	0

**Age**
From 65 to 74	192
From 75 to 84	132
85 and over	44
Less than 65	36

Hypertension	75
High Cholesterol	64
Stroke	8
Ischemic Heart Disease	37
Depression	28
Chronic Kidney Disease	48
Asthma	8
Osteoperosis	13
Atrial Fibrilation	18
Heart Failure	25
Chronic Obstructive Pulmonary Disease	24
Diabetes	34
Dementia	13
Cancer	54

blood draw	26
doctor visit	801
hospital care	179
inpatient care	179
lab tests	24

**Gender**
Male	158
Female	237

**Ethnicity**
Non-Hispanic White	359
Black	0
Hispanic	14
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	197
From 75 to 84	113
85 and over	47
Less than 65	38

Hypertension	72
High Cholesterol	64
Stroke	8
Ischemic Heart Disease	38
Depression	27
Chronic Kidney Disease	50
Asthma	8
Osteoperosis	11
Atrial Fibrilation	18
Heart Failure	28
Chronic Obstructive Pulmonary Disease	21
Diabetes	30
Dementia	12
Cancer	53

doctor visit	667
hospital care	142
inpatient care	142

**Gender**
Male	146
Female	233

**Ethnicity**
Non-Hispanic White	347
Black	0
Hispanic	11
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	193
From 75 to 84	102
85 and over	45
Less than 65	39

Hypertension	71
High Cholesterol	62
Stroke	6
Ischemic Heart Disease	39
Depression	30
Chronic Kidney Disease	48
Asthma	8
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	24
Chronic Obstructive Pulmonary Disease	15
Diabetes	31
Dementia	8
Cancer	59

doctor visit	1317
hospital care	346
inpatient care	346

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Muhammad Rizvi, MD for Medicare patients.

The highest averages for the top procedures that Dr. Muhammad Rizvi, MD treated as a medical oncologist in Allentown, PA were lab tests, hospital care, inpatient care and minimally invasive procedures.

biological response modifier (BRM) therapy	135
blood draw	110
chemotherapy	135
doctor visit	783
hospital care	240
inpatient care	240
lab tests	294
minimally invasive procedures	196
preventive care	11
vaccines	11

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Muhammad Rizvi, MD.

**Gender**
Male	153
Female	209

**Ethnicity**
Black / African American	11
Asian / Pacific Islander	0
Non-Hispanic White	320
Native American / Alaskan Native	0
Hispanic	7
Other	1

**Age**
75 to 84	116
85 and over	43
Less than 65	40
65 to 74	160

Average of Total of Conditions of Medicare patients treated by Dr. Muhammad Rizvi, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Muhammad Rizvi, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	59
High Cholesterol	50
Stroke	4
Ischemic Heart Disease	36
Depression	24
Chronic Kidney Disease	37
Asthma	11
Osteoporosis	11
Heart Failure	26
Chronic Obstructive Pulmonary Disease	21
Diabetes	28
Atrial Fibrillation	14
Cancer	33
Dementia	6

Education & Training

Dr. Muhammad Rizvi, MD graduated from Dow University of Health Sciences in 2001. He completed residency at SUNY, University at Buffalo Affiliated Hospitals. He is certified by the American Board of Internal Medicine - Internal Medicine and has a state license in Massachusetts.

Medical School: Dow University of Health Sciences (2001)

Residency: SUNY, University at Buffalo Affiliated Hospitals (2005)

Board Certification: American Board of Internal Medicine - Internal Medicine

Licensed In: Massachusetts

Affiliations & Hospitals

Dr. Muhammad Rizvi, MD is associated with these hospitals and organizations:

Lehigh Valley Physician Group (LVPG)

Lehigh Valley Health Network

LVH Hematology Oncology-1240 Cedar Crest

Ratings & Reviews

Dr. Muhammad Rizvi, MD has an exceptional overall rating with an average of 4.79 out of 5 stars based on 821 ratings. We collect ratings and reviews of Dr. Muhammad Rizvi, MD from all over the web to help you find the right in Allentown, PA.

4.79

Overall Rating

(821 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Muhammad Rizvi, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
AstraZeneca Pharmaceuticals LP	$1,948 IMFINZI $1,855	TAGRISSO $54	FASLODEX $39
E.R. Squibb & Sons, L.L.C.	$713 ERBITUX $198	OPDIVO $118	EMPLICITI $112	SPRYCEL $108	YERVOY $76	Other $101
Genentech USA, Inc.	$579 Erivedge $152	Rituxan $100	Gazyva $87	Venclexta $62	Alecensa $51	Other $128
Celgene Corporation	$542 Abraxane $380	Istodax $94	Pomalyst $47	Revlimid $21
Novartis Pharmaceuticals Corporation	$437 AFINITOR $113	TASIGNA $107	VOTRIENT RCC $54	PROMACTA $51	ZYKADIA $39	Other $72
Other	$1,881 IMBRUVICA $274	Vectibix $179	KEYTRUDA $85	Gilotrif $82	SGN35 $76	Other $1,185

**Types of Payments**
Food and Beverage	$3,978
Consulting Fee	$1,712
Education	$287
Travel and Lodging	$123

Research Payments

Dr. Muhammad Rizvi, MD has received 1 research payments totaling $22,200.

Biography

Dr. Muhammad Rizvi's specialties are general practice, medical oncology, and hematology (blood disorders). After attending Dow University of Health Sciences for medical school, he completed his residency training at a hospital affiliated with SUNY, University at Buffalo. Dr. Rizvi is affiliated with Lehigh Valley Physician Group (LVPG). He welcomes new patients at his office inAllentown, PA as reported by Lehigh Valley Health Network.